R&G PharmaStudies Co., Ltd. (SHE:301333)
66.19
-0.09 (-0.14%)
Mar 6, 2026, 4:00 PM EST
26.39% (1Y)
| Market Cap | 6.18B |
| Revenue (ttm) | 789.45M |
| Net Income (ttm) | 151.37M |
| Shares Out | 95.14M |
| EPS (ttm) | 1.59 |
| PE Ratio | 40.84 |
| Forward PE | 44.51 |
| Dividend | 0.16 (0.24%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 2,008,340 |
| Average Volume | 2,151,595 |
| Open | 66.21 |
| Previous Close | 66.28 |
| Day's Range | 65.00 - 68.50 |
| 52-Week Range | 40.99 - 91.78 |
| Beta | 0.71 |
| RSI | 38.86 |
| Earnings Date | Mar 28, 2026 |